정맥내 수액 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Intravenous Solutions Market size is expected to reach USD 40.91 Billion in 2034 from USD 19.81 Billion (2025) growing at a CAGR of 8.39% during 2026-2034.

The intravenous (IV) solutions market has shown steady expansion driven by rising hospital admissions, chronic disease management, and increased procedural volumes requiring parenteral fluids. Broad use of saline, dextrose, and balanced electrolyte solutions across emergency care, surgery, and critical care underpins consistent demand. Growth is supported by aging populations in developed markets and expanding hospital infrastructure in emerging economies, where access to standardized IV therapies is improving clinical outcomes and supporting market scale-up.

Key drivers comprise increasing surgical procedures, rising incidence of dehydration and sepsis, and a growing preference for balanced crystalloids over traditional saline in certain clinical settings. Regulatory scrutiny and quality-control requirements push manufacturers toward GMP-compliant production with stringent sterility and packaging standards. Supply-chain resilience has become a core concern following episodic shortages; consequently, manufacturers invest in redundant capacity, regional fill-and-finish sites, and improved cold-chain logistics for specialty parenteral formulations.

Future prospects include growth in premixed and customized IV bags, expansion into ambulatory infusion services, and formulation innovations (electrolyte-balanced solutions tailored to specific patient populations). Biosensor-enabled IV pumps and connected infusion management may create adjunct service opportunities for manufacturers. Market entrants who can guarantee supply security, demonstrate cost-effective manufacturing, and support hospital formularies through clinical data will capture incremental share as healthcare systems globally push for reliable, high-quality parenteral therapy supplies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Composition

• Carbohydrates
• Vitamins And Minerals
• Single-Dose Amino Acids
• Parenteral Lipid Emulsion
• Other Compositions

By Age Group

• Pediatric
• Adults
• Geriatric

By Application

• Nutritional Support
• Blood Transfusion
• Fluid And Electrolyte Balance
• Other Applications

By End Use

• Hospitals And Clinics
• Ambulatory Surgery Centers
• Home Care Settings

COMPANIES PROFILED

• AdvaCare Pharma, Amanta Healthcare, Axa Parenterals, B Braun, Baxter International, Fresenius Kabi, Grifols, ICU Medical, JW Life Science, Otsuka Pharmaceutical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Total Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Peripheral Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY COMPOSITION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Composition
• 5.2. Carbohydrates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Vitamins And Minerals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Single-Dose Amino Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Parenteral Lipid Emulsion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Compositions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Geriatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Nutritional Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Blood Transfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Fluid And Electrolyte Balance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Composition
  • 9.2.3 By Age Group
  • 9.2.4 By Application
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Composition
  • 9.3.3 By Age Group
  • 9.3.4 By Application
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Composition
  • 9.4.3 By Age Group
  • 9.4.4 By Application
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Composition
  • 9.5.3 By Age Group
  • 9.5.4 By Application
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Composition
  • 9.6.3 By Age Group
  • 9.6.4 By Application
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INTRAVENOUS SOLUTIONS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 AdvaCare Pharma
  • 11.2.2 Amanta Healthcare
  • 11.2.3 Axa Parenterals
  • 11.2.4 B. Braun
  • 11.2.5 Baxter International
  • 11.2.6 Fresenius Kabi
  • 11.2.7 Grifols
  • 11.2.8 ICU Medical
  • 11.2.9 JW Life Science
  • 11.2.10 Otsuka Pharmaceutical